BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 7006681)

  • 1. Inhibition of orotidine-5'-phosphate decarboxylase by 1-(5'-phospho-beta-d-ribofuranosyl)barbituric acid, 6-azauridine 5'-phosphate, and uridine 5'-phosphate.
    Levine HL; Brody RS; Westheimer FH
    Biochemistry; 1980 Oct; 19(22):4993-9. PubMed ID: 7006681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymer-linked 6-azauridine 5'-monophosphate, a resin of high bioaffinity to orotidine-5'-phosphate decarboxylase.
    Rosemeyer H; Seela F
    J Med Chem; 1979 Dec; 22(12):1545-7. PubMed ID: 94096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substrate binding induces domain movements in orotidine 5'-monophosphate decarboxylase.
    Harris P; Poulsen JC; Jensen KF; Larsen S
    J Mol Biol; 2002 May; 318(4):1019-29. PubMed ID: 12054799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystallization of yeast orotidine 5'-monophosphate decarboxylase complexed with 1-(5'-phospho-beta-D-ribofuranosyl) barbituric acid.
    Bell JB; Jones ME; Carter CW
    Proteins; 1991; 9(2):143-51. PubMed ID: 2008434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Theoretical drug design: 6-azauridine-5'-phosphate--its X-ray crystal structure, potential energy maps, and mechanism of inhibition of orotidine-5'-phosphate decarboxylase.
    Saenger W; Suck D; Knappenberg M; Dirkx J
    Biopolymers; 1979 Aug; 18(8):2015-36. PubMed ID: 497352
    [No Abstract]   [Full Text] [Related]  

  • 6. Structural basis for the catalytic mechanism of a proficient enzyme: orotidine 5'-monophosphate decarboxylase.
    Harris P; Navarro Poulsen JC; Jensen KF; Larsen S
    Biochemistry; 2000 Apr; 39(15):4217-24. PubMed ID: 10757968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 6-Azauridine-5'-phosphoric acid: unusual molecular structure and functional mechanism.
    Saenger W; Suck D
    Nature; 1973 Apr; 242(5400):610-2. PubMed ID: 4621097
    [No Abstract]   [Full Text] [Related]  

  • 8. Metabolic resistance to tight-binding inhibitors of enzymes involved in the de novo pyrimidine pathway. Simulation of time-dependent effects.
    Duggleby RG; Christopherson RI
    Eur J Biochem; 1984 Aug; 143(1):221-6. PubMed ID: 6468388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification and characterization of yeast orotidine 5'-monophosphate decarboxylase overexpressed from plasmid PGU2.
    Bell JB; Jones ME
    J Biol Chem; 1991 Jul; 266(19):12662-7. PubMed ID: 2061334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of enzyme-ribofuranosyl contacts in the ground state and transition state for orotidine 5'-phosphate decarboxylase: a role for substrate destabilization?
    Miller BG; Butterfoss GL; Short SA; Wolfenden R
    Biochemistry; 2001 May; 40(21):6227-32. PubMed ID: 11371183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A reexamination of the substrate utilization of 2-thioorotidine-5'-monophosphate by yeast orotidine-5'-monophosphate decarboxylase.
    Smiley JA; Hay KM; Levison BS
    Bioorg Chem; 2001 Apr; 29(2):96-106. PubMed ID: 11300698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A proficient enzyme revisited: the predicted mechanism for orotidine monophosphate decarboxylase.
    Lee JK; Houk KN
    Science; 1997 May; 276(5314):942-5. PubMed ID: 9139656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does the bifunctional uridylate synthase channel orotidine 5'-phosphate? Kinetics of orotate phosphoribosyltransferase and orotidylate decarboxylase activities fit a noninteracting sites model.
    McClard RW; Shokat KM
    Biochemistry; 1987 Jun; 26(12):3378-84. PubMed ID: 3651388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of the enzyme complex that synthesizes UMP in Ehrlich ascites cells.
    Traut TW
    Arch Biochem Biophys; 1980 Apr; 200(2):590-4. PubMed ID: 7002045
    [No Abstract]   [Full Text] [Related]  

  • 15. Rapid conversion of newly-synthesized orotate to uridine-5-monophosphate by rat liver cytosolic enzymes.
    Dileepan KN; Kennedy J
    FEBS Lett; 1983 Mar; 153(1):1-5. PubMed ID: 6186531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Yeast orotidine-5'-phosphate decarboxylase: steady-state and pre-steady-state analysis of the kinetic mechanism of substrate decarboxylation.
    Porter DJ; Short SA
    Biochemistry; 2000 Sep; 39(38):11788-800. PubMed ID: 10995247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catalysis by orotidine 5'-monophosphate decarboxylase: effect of 5-fluoro and 4'-substituents on the decarboxylation of two-part substrates.
    Goryanova B; Spong K; Amyes TL; Richard JP
    Biochemistry; 2013 Jan; 52(3):537-46. PubMed ID: 23276261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of orotidine 5'-monophosphate decarboxylase in complex with the top three OMP, BMP, and PMP ligands by molecular dynamics simulation.
    Jamshidi S; Jalili S; Rafii-Tabar H
    J Biomol Struct Dyn; 2015; 33(2):404-17. PubMed ID: 24559040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of orotidine-5'-monophosphate decarboxylase--discoveries and lessons.
    Kotra LP; Pai EF
    Nucleic Acids Symp Ser (Oxf); 2008; (52):85-6. PubMed ID: 18776265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design of inhibitors of orotidine monophosphate decarboxylase using bioisosteric replacement and determination of inhibition kinetics.
    Poduch E; Bello AM; Tang S; Fujihashi M; Pai EF; Kotra LP
    J Med Chem; 2006 Aug; 49(16):4937-45. PubMed ID: 16884305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.